Geode Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$65.2M Buy
3,024,097
+69,584
+2% +$1.5M ﹤0.01% 1280
2025
Q1
$49.1M Buy
2,954,513
+77,404
+3% +$1.29M ﹤0.01% 1386
2024
Q4
$52.8M Buy
2,877,109
+1,569
+0.1% +$28.8K ﹤0.01% 1398
2024
Q3
$44.2M Buy
2,875,540
+30,826
+1% +$474K ﹤0.01% 1503
2024
Q2
$46.2M Buy
2,844,714
+51,477
+2% +$837K ﹤0.01% 1415
2024
Q1
$51.7M Buy
2,793,237
+101,085
+4% +$1.87M ﹤0.01% 1328
2023
Q4
$84.3M Buy
2,692,152
+113,770
+4% +$3.56M 0.01% 973
2023
Q3
$53.7M Buy
2,578,382
+84,044
+3% +$1.75M 0.01% 1187
2023
Q2
$59.7M Buy
2,494,338
+104,071
+4% +$2.49M 0.01% 1118
2023
Q1
$45M Buy
2,390,267
+90,768
+4% +$1.71M 0.01% 1272
2022
Q4
$36.6M Buy
2,299,499
+78,348
+4% +$1.25M 0.01% 1367
2022
Q3
$36.3M Buy
2,221,151
+60,167
+3% +$984K 0.01% 1320
2022
Q2
$30.4M Sell
2,160,984
-41,441
-2% -$584K ﹤0.01% 1469
2022
Q1
$53.3M Buy
2,202,425
+38,273
+2% +$927K 0.01% 1213
2021
Q4
$50.5M Buy
2,164,152
+143,000
+7% +$3.34M 0.01% 1307
2021
Q3
$33.6M Sell
2,021,152
-54,148
-3% -$899K ﹤0.01% 1606
2021
Q2
$50.6M Buy
2,075,300
+608,790
+42% +$14.8M 0.01% 1293
2021
Q1
$37.8M Buy
1,466,510
+47,298
+3% +$1.22M 0.01% 1448
2020
Q4
$75.9M Buy
1,419,212
+88,896
+7% +$4.75M 0.01% 837
2020
Q3
$54.9M Sell
1,330,316
-40,187
-3% -$1.66M 0.01% 864
2020
Q2
$66.4M Sell
1,370,503
-357,567
-21% -$17.3M 0.01% 737
2020
Q1
$73M Buy
1,728,070
+107,011
+7% +$4.52M 0.02% 599
2019
Q4
$69.3M Buy
1,621,059
+128,565
+9% +$5.5M 0.01% 761
2019
Q3
$53.7M Buy
1,492,494
+4,662
+0.3% +$168K 0.01% 838
2019
Q2
$39.8M Buy
1,487,832
+66,169
+5% +$1.77M 0.01% 1018
2019
Q1
$38.2M Buy
1,421,663
+176,724
+14% +$4.74M 0.01% 981
2018
Q4
$20.1M Buy
1,244,939
+177,701
+17% +$2.87M 0.01% 1269
2018
Q3
$22.2M Buy
1,067,238
+62,605
+6% +$1.3M 0.01% 1339
2018
Q2
$15.3M Buy
1,004,633
+99,084
+11% +$1.51M ﹤0.01% 1552
2018
Q1
$20.3M Buy
905,549
+35,572
+4% +$799K 0.01% 1247
2017
Q4
$26.2M Buy
869,977
+24,847
+3% +$748K 0.01% 1079
2017
Q3
$31.8M Buy
845,130
+54,720
+7% +$2.06M 0.01% 923
2017
Q2
$22M Buy
790,410
+29,578
+4% +$825K 0.01% 1104
2017
Q1
$26.2M Buy
760,832
+63,421
+9% +$2.18M 0.01% 978
2016
Q4
$20.1M Buy
697,411
+25,728
+4% +$742K 0.01% 1076
2016
Q3
$21.4M Buy
671,683
+23,594
+4% +$751K 0.01% 958
2016
Q2
$21M Sell
648,089
-26,928
-4% -$874K 0.01% 918
2016
Q1
$18.9K Buy
675,017
+126,169
+23% +$3.53K 0.01% 963
2015
Q4
$19.6M Buy
548,848
+15,058
+3% +$537K 0.01% 910
2015
Q3
$17.7M Buy
533,790
+14,477
+3% +$479K 0.01% 951
2015
Q2
$21.7M Buy
519,313
+15,427
+3% +$646K 0.01% 883
2015
Q1
$16.4M Buy
503,886
+14,570
+3% +$475K 0.01% 1036
2014
Q4
$15.5M Buy
489,316
+11,258
+2% +$357K 0.01% 1027
2014
Q3
$11.8M Buy
478,058
+5,806
+1% +$144K 0.01% 1136
2014
Q2
$10.7M Buy
472,252
+29,337
+7% +$663K 0.01% 1254
2014
Q1
$10.8M Buy
442,915
+59,289
+15% +$1.44M 0.01% 1200
2013
Q4
$9.59M Buy
383,626
+53,240
+16% +$1.33M 0.01% 1212
2013
Q3
$9.08M Buy
330,386
+27,754
+9% +$762K 0.01% 1141
2013
Q2
$5.49M Buy
+302,632
New +$5.49M ﹤0.01% 1345